Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Genetic diversity and antifungal susceptibility of Candida haemulonii complex

PROVIDER: PRJNA938413 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR23610439_1.fastq.gz	Fastqsanger.gz
	SRR23610439_2.fastq.gz	Fastqsanger.gz
	SRR23610440_1.fastq.gz	Fastqsanger.gz
	SRR23610440_2.fastq.gz	Fastqsanger.gz
	SRR23610441_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 101

Similar Datasets

Transcriptional Signatures Predict Phenotypic Variations of Candida auris

Project description:Transcriptomic analysis of different Candida auris clinical isolates with distinct antifungal susceptibility profiles.

2021-01-30 | GSE165762 | GEO

Whole genome sequencing of fluconazole-resistant mutants in Candida haemulonii

Project description:Candida haemulonii wild type strain TJ180 were expsoured to 64 and 128 μg/ml fluconazole. 14 resistant mutants as well as the parent were sequenced.

2024-01-10 | E-MTAB-13199 | biostudies-arrayexpress

Project description:Candida haemulonii species complex whole genome sequencing and assembly

| PRJNA1002224 | ENA

Isolate specific transcriptome changes exerted by isavuconazole treatment in Candida auris

Project description:Invasive fungal infections are important healthcare associated disease worldwide especially in intensive care units More recently, Candida auris a multidrug and potentially pan-resistant species has globally emerged as a new nosocomial pathogen, which has been already reported from at least 50 countries on six continents. Clinical studies showed that previously well-defined phylogenetic C. auris clades display significant differences regarding their pathogenicity, virulence, metabolism and susceptibility profile to traditional antifungal therapies. Based on epidemiological data, isolates belonging to the South Asian clade show the highest ratio of resistance to fluconazole (97%), amphotericin B (47%) and this clade involves the highest number of multidrug resistant isolates (45%), which compromise the efficacy of applied antifungal therapy. In the past decade, a new broad-spectrum antifungal drug, isavuconazole (ISA), has been introduced into clinical practice. ISA is primarily approved for the treatment of invasive aspergillosis and mucormycosis, and currently, there are no available recommendations for the therapy of invasive Candida infections. In our previous study, we reported different ISA susceptibility profiles between isolates belonging to South Asian lineage. However, the global transcriptional - even isolate specific - response remained unresolved. Therefore, our study aimed to reveal those molecular events, which are associated with ISA exposure using high throughput RNA sequencing (RNAseq).

2024-08-24 | GSE275177 | GEO

Functional genomics identifies type I interferon pathway as central for host defense against Candida albicans

Project description:Candida albicans is the most common human fungal pathogen causing mucosal and systemic infections. However, human antifungal immunity remains poorly defined. By integrating transcriptional analysis and functional genomics we identified Candida-specific host defense mechanisms in humans. Candida induced significant (p<10-35) expression of genes from the type I interferon (IFN) pathway in human peripheral blood mononuclear cells. This unexpectedly prominent role of type I IFN pathway in anti-Candida host defense was supported by additional evidence. Polymorphisms in type I IFN genes modulated Candida-induced cytokine production and were correlated with susceptibility to systemic candidiasis. In in-vitro experiments, type I IFNs skewed Candida-induced inflammation from a Th17-response toward a Th1-response. Patients with chronic mucocutaneaous candidiasis displayed defective expression of genes in the type I IFN pathway. These findings indicate that the type I IFN pathway is a main signature of Candida-induced inflammation and plays a crucial role in anti-Candida host defense in humans.

2012-12-01 | GSE42630 | GEO

Functional genomics identifies type I interferon pathway as central for host defense against Candida albicans

2012-12-01 | E-GEOD-42630 | biostudies-arrayexpress

Candidozyma haemuli strain:BMU05228

Project description:Candida haemulonii Genome sequencing and assembly

| PRJNA541353 | ENA

Diutina catenulata

Project description:Antifungal susceptibility profiles and drug resistant mechanisms of clinical Candida catenulata isolates

| PRJNA757603 | ENA

Diutina catenulata

Project description:Antifungal susceptibility profiles and drug resistant mechanisms of clinical Candida catenulata isolates

| PRJNA757630 | ENA